Home Articles 2004 Page 3

2004

Random

OpEd: Vioxx Withdrawal and the “Me-Too Drug Domino Effect”

Pharma Guy - October 1, 2004

Pharma Marketing News Vol. 3, #4 (Apr 2004) Archive

Pharma Guy - April 1, 2004

A Crisis in Professional Detailing

Pharma Guy - July 1, 2004

Pharma Marketing News Vol. 3, #7 (July/August 2004) Archive

Pharma Guy - July 1, 2004

Your Pharma Marketing Sucks

Pharma Guy - March 1, 2004

Controlling Your Brand’s Switch Destiny

Pharma Guy - January 1, 2004

Maximizing the DTC Message: Healthcare Businesswomen’s Association Members Evaluate DTC Marketing

Pharma Guy - April 1, 2004

European Compliance Not Only Possible, But Leading Edge

Pharma Guy - May 1, 2004

The Truth About the Drug Companies: What To Do About It

Pharma Guy - November 1, 2004

Commercial Support of CME: When is it Appropriate?

Pharma Guy - April 1, 2004

1 234...8 Page 3 of 8

EDITOR PICKS

Inside THCP2026: How Pharma Is Rethinking Transparency, HCP Engagement and Compliance

August 14, 2026

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

TrumpRx pharma marketing concept showing prescription drug discovery, pricing, pharmacy access, and the federal government’s role in the patient journey.

What Happens When the Government Enters the Pharma Customer Journey?

August 21, 2026

Patient using an accessible pharmaceutical website with features for readable text, keyboard navigation, captions, and screen readers.

Can Every Patient Actually Use Your Pharma Website?

August 21, 2026

FDA Complete Response Letter on a pharmaceutical regulatory desk with clinical data and drug application documents

Your Drug Didn’t Get Approved. Now the FDA Can Tell Everyone...

August 20, 2026